Shah Gaurav 4

What Happened
Gaurav Shah, CEO of Rocket Pharmaceuticals, sold 5,990 shares of common stock on 2026-02-18 at $3.34 per share, generating $19,995 in proceeds. The sale was made to satisfy tax withholding obligations related to the vesting of restricted stock units (RSUs).

Key Details

• Transaction date: 2026-02-18; filing date: 2026-02-20 (appears timely).
• Transaction type/code: Open-market/private sale (S).
• Shares sold: 5,990 at $3.34 each; total proceeds ~$19,995.
• Shares owned after transaction: Not specified in the Form 4 excerpt.
• Footnotes: F1 — holdings include RSUs that convert one-for-one to common stock. F2 — shares sold to pay tax withholding on RSU vesting.
• No indication of a 10b5-1 plan or late filing in this report.

Context
This sale was executed specifically to cover tax withholding for RSU vesting, per the filer’s note—an administrative transaction rather than an outright investment decision. Such withholding sales are common and do not necessarily indicate the CEO’s view on the company’s prospects.